Literature DB >> 16501852

Novel pathophysiological concepts of inflammatory bowel disease.

Toshifumi Hibi1, Haruhiko Ogata.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16501852     DOI: 10.1007/s00535-005-1744-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  61 in total

Review 1.  Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.

Authors:  Akira Andoh; Shigeki Bamba; Yoshihide Fujiyama; Mairi Brittan; Nicholas A Wright
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

2.  Significant role of genetics in IBD: the NOD2 gene.

Authors:  Judy H Cho
Journal:  Rev Gastroenterol Disord       Date:  2003

3.  Association of NOD2 with Crohn's disease in a homogenous Irish population.

Authors:  Emer Bairead; Dawn L Harmon; Anne M Curtis; Yvette Kelly; Clare O'Leary; Michelle Gardner; Dermot T Leahy; Pat Vaughan; Denise Keegan; Colm O'Morain; Diarmuid O'Donoghue; Fergus Shanahan; Nollaig A Parfrey; Kathleen A Quane
Journal:  Eur J Hum Genet       Date:  2003-03       Impact factor: 4.246

4.  Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts.

Authors:  Osamu Inatomi; Akira Andoh; Ken-Ichi Kitamura; Hirofumi Yasui; Zhuobin Zhang; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-05       Impact factor: 7.527

5.  Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment.

Authors:  Osamu Kanauchi; Isao Serizawa; Yoshio Araki; Asuka Suzuki; Akira Andoh; Yoshihide Fujiyama; Keiichi Mitsuyama; Kosuke Takaki; Atsushi Toyonaga; Michio Sata; Tadao Bamba
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

6.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

7.  Intestinal subepithelial myofibroblasts in inflammatory bowel diseases.

Authors:  Akira Andoh; Sanae Fujino; Takafumi Okuno; Yoshihide Fujiyama; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 8.  Molecular and clinical basis for the regeneration of human gastrointestinal epithelia.

Authors:  Ryuichi Okamoto; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2004-01       Impact factor: 7.527

Review 9.  Mucosal T cells as a target for treatment of IBD.

Authors:  Mamoru Watanabe; Motomi Yamazaki; Takanori Kanai
Journal:  J Gastroenterol       Date:  2003-03       Impact factor: 7.527

Review 10.  Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.

Authors:  Paolo Puccetti; Maria L Belladonna; Ursula Grohmann
Journal:  Crit Rev Immunol       Date:  2002       Impact factor: 2.214

View more
  52 in total

1.  Hsp60 and Hsp10 increase in colon mucosa of Crohn’s disease and ulcerative colitis.

Authors:  Vito Rodolico; Giovanni Tomasello; Monica Zerilli; Anna Martorana; Alessandro Pitruzzella; Antonella Marino Gammazza; Sabrina David; Giovanni Zummo; Provvidenza Damiani; Salvatore Accomando; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2010-11       Impact factor: 3.667

2.  Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

Authors:  Jida Choi; Suyoung Bae; Jaewoo Hong; Soyoon Ryoo; Hyunjhung Jhun; Kwangwon Hong; Doyoung Yoon; Siyoung Lee; Erk Her; Wonhyuk Choi; Jeonghwan Kim; Tania Azam; Charles A Dinarello; Soohyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 3.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.

Authors:  Koichi Yanaba; Ayumi Yoshizaki; Yoshihide Asano; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 5.  Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.

Authors:  Yuji Naito; Tomohisa Takagi; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

6.  A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.

Authors:  Atsushi Sakuraba; Toshiro Sato; Makoto Naganuma; Yuichi Morohoshi; Katsuyoshi Matsuoka; Nagamu Inoue; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

7.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

8.  Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.

Authors:  Yuhki Yagi; Akira Andoh; Osamu Inatomi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

9.  Regulation of IL12B Expression in Human Macrophages by TALEN-mediated Epigenome Editing.

Authors:  Meng Chen; Hua Zhu; Yu-Juan Mao; Nan Cao; Ya-Li Yu; Lian-Yun Li; Qiu Zhao; Min Wu; Mei Ye
Journal:  Curr Med Sci       Date:  2020-10-29

10.  Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Authors:  Atsushi Sakuraba; Kian Keyashian; Chase Correia; John Melek; Russell D Cohen; Stephen B Hanauer; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.